Helen McBreen
Partner @ Atlantic Bridge
Dublin, Ireland
Helen McBreen is a seed investor at Atlantic Bridge in Dublin focused on Sports and Medical. Helen McBreen is based out of Dublin and is the Partner of Atlantic Bridge. Helen previously worked at NDRC as a Commercial Development Leader. Helen McBreen attended the University College Dublin. Helen McBreen has received Top 100 Women in STEM award.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Helen McBreen invests in
Stages Helen McBreen invests in
Countries Helen McBreen invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Sports 1 (20%)
- Medical 1 (20%)
- Big Data 1 (20%)
- Hospital 1 (20%)
- Health Care 1 (20%)
Stage
- Seed 2 (40%)
- Funding Round 2 (40%)
- Series A 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Output Sports operates as a sports tech start-up. We are revolutionizing the way athletic staff optimize sports performance. Using advanced signal processing and machine learning techniques we have developed an end-to-end solution that can test multiple components of athletic performance and track training programmes with a single wearable sensor. | $4.8M / Seed / Jan 30, 2025 | ||
| It has been estimated that up to 25% of diabetics will develop a foot ulcer at some point in their life. One of the main causes is peripheral neuropathy, which results in a patient losing sensation in their feet. Of the millions who develop ulcers every year, hundreds of thousands will require amputation due to infection. In 2014, Ireland recordedan increase in the number of amputations as a result of diabetes, with 8 limbs being lost every week. | $11.5M / Mar 31, 2023 | ||
| It has been estimated that up to 25% of diabetics will develop a foot ulcer at some point in their life. One of the main causes is peripheral neuropathy, which results in a patient losing sensation in their feet. Of the millions who develop ulcers every year, hundreds of thousands will require amputation due to infection. In 2014, Ireland recordedan increase in the number of amputations as a result of diabetes, with 8 limbs being lost every week. | $11.4M / Seed / Mar 31, 2023 | ||
| Aylien is an artificial intelligence startup that focuses on creating technologies that help machines understand human languages better. The firm provides Text Analysis and News API's that allow users to make sense of human-generated content at scale. AYLIEN also provides a range of content analysis solutions to developers, data scientists,marketers and academics. Their core offerings include packages of information retrieval, machine learning, natural language processing and image recognition APIs. | $5.5M / Series A / Dec 20, 2019 | ||
| Aylien is an artificial intelligence startup that focuses on creating technologies that help machines understand human languages better. The firm provides Text Analysis and News API's that allow users to make sense of human-generated content at scale. AYLIEN also provides a range of content analysis solutions to developers, data scientists,marketers and academics. Their core offerings include packages of information retrieval, machine learning, natural language processing and image recognition APIs. | $2.5M / Aug 21, 2017 |
Co-Investors
About Atlantic Bridge
Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.
Atlantic Bridge Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Brian Long
Managing Partner
|
|||
Gerry Maguire
Co-Founder and General Partner
|
|||
|
Helen McBreen
Partner
|
|||
Kevin Dillon
Managing Partner & Co-Founder
|
|||
Chris Horn
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Helen McBreen invest in?
Helen McBreen invests primarily in Sports, Medical and Big Data startups, most often at Seed and Funding Round stage. Most of the 5 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Helen McBreen?
Public channels for Helen McBreen include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Helen McBreen last invest?
The most recent investment recorded for Helen McBreen closed in Jan 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
